![](/img/cover-not-exists.png)
Comparison of acalabrutinib plus obinutuzumab, ibrutinib plus obinutuzumab and venetoclax plus obinutuzumab for untreated CLL: a network meta-analysis
Sheng, Zhixin, Song, Shilei, Yu, Miao, Zhu, Hongguang, Gao, Anran, Gao, Weijie, Ran, Xuehong, Huo, DaJournal:
Leukemia & Lymphoma
DOI:
10.1080/10428194.2020.1811271
Date:
August, 2020
File:
PDF, 1.96 MB
2020